These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32568949)

  • 21. Time to normalisation of C-reactive protein and incidence of relapse in microscopic polyangiitis: A medical records review study in Japan.
    Yamaguchi M; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Katsuno T; Ando M; Kubo Y; Banno S; Ito Y; Ishimoto T
    Mod Rheumatol; 2023 Dec; 34(1):151-156. PubMed ID: 36495202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary involvement in antineutrophil cytoplasmic antibody-associated vasculitides.
    Pella E; Iatridi F; Sgouropoulou V; Boutou A; Dimitroulas T
    Int J Rheum Dis; 2024 Jan; 27(1):e14933. PubMed ID: 37753535
    [No Abstract]   [Full Text] [Related]  

  • 23. Central Retinal Artery Occlusion Leading to Diagnosis of Eosinophilic Granulomatous Polyangiitis After Adenovirus Vector COVID-19 Vaccination.
    Moses MM; Fischer NA; Elston C; Dib B
    J Vitreoretin Dis; 2024; 8(4):471-475. PubMed ID: 39148575
    [No Abstract]   [Full Text] [Related]  

  • 24. Microscopic polyangiitis presenting with purpura and intermittent claudication.
    Ishizuka K; Ohira Y
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37558280
    [No Abstract]   [Full Text] [Related]  

  • 25. Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach?
    Gill B; Putman M
    Lancet Rheumatol; 2023 Dec; 5(12):e698-e699. PubMed ID: 38251556
    [No Abstract]   [Full Text] [Related]  

  • 26. A case of microscopic polyangiitis with acute-onset visual acuity loss.
    Wang Y; Xu Y
    Int Urol Nephrol; 2024 Mar; 56(3):1197-1198. PubMed ID: 37608031
    [No Abstract]   [Full Text] [Related]  

  • 27. Tongue necrosis in anti-neutrophil myeloperoxidase antibody-associated vasculitis.
    Korsten P; Hakroush S; Rödel R; Tampe B
    Rheumatology (Oxford); 2024 Feb; 63(2):e61-e62. PubMed ID: 37458489
    [No Abstract]   [Full Text] [Related]  

  • 28. Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
    Sun R; Wei LJ
    N Engl J Med; 2024 May; 390(20):1939. PubMed ID: 38810203
    [No Abstract]   [Full Text] [Related]  

  • 29. A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody-related vasculitis criteria sets: comment on criteria sets approved by the American College of Rheumatology Board of Directors and the European Alliance of Associations for Rheumatology Executive Committee.
    Yazici H; Yazici Y
    Arthritis Rheumatol; 2022 Oct; 74(10):1724-1725. PubMed ID: 35714043
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis.
    Caminati M; Scarpieri E; Maule M; Pinter P; Schiappoli M; Vaia R; Senna G
    Rheumatology (Oxford); 2024 Mar; 63(3):e96-e98. PubMed ID: 37695303
    [No Abstract]   [Full Text] [Related]  

  • 31. The conclusion that myeloperoxidase inhibition is not protective against anti-neutrophil cytoplasmic autoantibody-associated vasculitis is premature.
    Taniguchi T; Hiwa R; Morinobu A
    Kidney Int; 2023 Oct; 104(4):856. PubMed ID: 37739617
    [No Abstract]   [Full Text] [Related]  

  • 32. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases.
    Yoshihara R; Komai T; Shoda H; Fujio K
    Int J Rheum Dis; 2020 Nov; 23(11):1534-1540. PubMed ID: 33051990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis.
    Vultaggio A; Nencini F; Bormioli S; Vivarelli E; Dies L; Rossi O; Parronchi P; Maggi E; Matucci A
    Allergy Asthma Immunol Res; 2020 Sep; 12(5):885-893. PubMed ID: 32638567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies.
    Tsuchiya H; Iwasaki Y; Shoda H; Takahashi Y; Fujio K
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):250-253. PubMed ID: 33441041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RORα is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus.
    Ferreira ACF; Szeto ACH; Heycock MWD; Clark PA; Walker JA; Crisp A; Barlow JL; Kitching S; Lim A; Gogoi M; Berks R; Daly M; Jolin HE; McKenzie ANJ
    Nat Immunol; 2021 Feb; 22(2):166-178. PubMed ID: 33432227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two cases of refractory eosinophilic granulomatosis with polyangiitis wherein mepolizumab was effective against pulmonary and ear lesions.
    Ushio Y; Wakiya R; Kato M; Kameda T; Nakashima S; Shimada H; Mansour MMF; Sugihara K; Miyashita T; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):327-332. PubMed ID: 33533698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis.
    Masumoto N; Oshikata C; Nakadegawa R; Motobayashi Y; Osada R; Manabe S; Kaneko T; Tsurikisawa N
    Allergy Asthma Clin Immunol; 2023 May; 19(1):40. PubMed ID: 37179316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab.
    Tamechika SY; Isogai S; Maeda S; Naniwa T; Niimi A
    Case Rep Rheumatol; 2021; 2021():5561762. PubMed ID: 33859858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody by Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis.
    Komai T; Harada H; Takahashi H; Shoda H; Fujio K
    J Clin Rheumatol; 2021 Dec; 27(8S):S806-S807. PubMed ID: 32568949
    [No Abstract]   [Full Text] [Related]  

  • 40. Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?
    von Deimling M; Koehler TC; Frye BC; Maerker-Hermann E; Venhoff N
    Ann Rheum Dis; 2023 Apr; 82(4):580-582. PubMed ID: 36600316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.